Pre-market Hot Trades in US Stocks
Amer Sports is up 7.01% in pre-market trading. According to recent key news:
<ol>
<li>
On September 18, Amer Sports raised its financial guidance for the third quarter of 2025, expecting revenue growth to exceed 20%, with adjusted operating profit margins reaching or exceeding the high end of 12% to 13%. This news drove the stock price up. Source: MT Newswires.
</li>
<li>
On September 18, Amer Sports reaffirmed its long-term financial algorithm during its Investor Day event and raised its financial guidance for the third quarter, with CEO James Zheng expecting strong quarterly performance across all departments. Source: Reuters.
</li>
<li>
On September 17, the trend of recovering consumer investment enhanced market confidence in consumer stocks like Amer Sports, driving the stock price up. Source: Investor Commentary. The consumer sector is recovering, and market confidence is strengthening.
</li>
</ol>
Top Gainers in Pre-market US Stocks
89bio is up 87.38% in pre-market trading. Based on recent important news:
<ol>
<li>
On September 18, Roche announced it would acquire 89bio for $14.50 per share in cash, with a total transaction value of up to $3.5 billion. This news led to a significant increase in 89bio's stock price.
</li>
<li>
On September 18, 89bio's key drug pegozafermin is considered to have great potential in treating moderate to severe metabolic dysfunction-associated steatotic liver disease (MASH), further boosting market confidence in its future development.
</li>
<li>
On September 18, analysts expressed optimism about 89bio's acquisition deal, believing in the huge market potential of MASH, supporting a buy rating for the stock. The biopharmaceutical industry is active in mergers and acquisitions, increasing market volatility.
</li>
</ol>
Aptevo Therapeutics is up 60.94% in pre-market trading. Based on recent key news:
<ol>
<li>
On September 16, Aptevo Therapeutics announced that its acute myeloid leukemia (AML) RAINIER trial's Cohort 3 achieved a 100% remission rate. This news drove the company's stock price up by 57%.
</li>
<li>
On September 16, Aptevo's trading volume surged, with approximately 34 million shares changing hands, compared to an average of about 165,000 shares over the past three months.
</li>
<li>
On September 17, despite facing financial challenges, Aptevo's positive progress in its oncology pipeline provides potential upside for the future. The biotechnology sector has been active recently.
</li>
</ol>
Datavault AI is up 53.55%. No recent news

QVCGA

QVC pre-market up 7.79%; Amer Sports pre-market up 7.01%; 89bio pre-market up 87.38%; Aptevo Therap pre-market up 60.94%; Datavault AI pre-market up 53.55%

Pre-market hot trades in US stocks: QVC up 7.79% pre-market; Amer Sports up 7.01% pre-market